Evidence map›Paper›PMID 42784355›Full record

ArticleTropical medicine and infectious disease2026

María A Occhionero, Daniela A Gaspar, Daniela E Barraza, María Elisa Vázquez, Brenda A Zabala, Rita A Sandoval, Lucila Saavedra, Cecilia Pérez Brandán, Natalia S Corbalán, Leonardo Acuña

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tropical medicine and infectious disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

María A OcchioneroUnidad de Biotecnología y Protozoarios (UBIPRO), Instituto de Patología Experimental "Dr. Miguel Ángel Basombrío" (IPE), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Nacional de Salta, Salta A4400, Argentina.
Daniela A GasparUnidad de Biotecnología y Protozoarios (UBIPRO), Instituto de Patología Experimental "Dr. Miguel Ángel Basombrío" (IPE), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Nacional de Salta, Salta A4400, Argentina.ORCID 0009-0000-5675-7879
Daniela E BarrazaUnidad de Biotecnología y Protozoarios (UBIPRO), Instituto de Patología Experimental "Dr. Miguel Ángel Basombrío" (IPE), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Nacional de Salta, Salta A4400, Argentina.
María Elisa VázquezUnidad de Biotecnología y Protozoarios (UBIPRO), Instituto de Patología Experimental "Dr. Miguel Ángel Basombrío" (IPE), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Nacional de Salta, Salta A4400, Argentina.ORCID 0000-0002-8202-3614
Brenda A ZabalaUnidad de Biotecnología y Protozoarios (UBIPRO), Instituto de Patología Experimental "Dr. Miguel Ángel Basombrío" (IPE), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Nacional de Salta, Salta A4400, Argentina.
Rita A SandovalLaboratorio de Biotecnología Microbiana, Escuela de Biología-Facultad de Ciencias Naturales, Universidad Nacional de Salta, Salta A4400, Argentina.
Lucila SaavedraLaboratorio de Genética y Biología Molecular, Centro de Referencia para Lactobacilos (CERELA), San Miguel de Tucumán A4000, Argentina.ORCID 0000-0003-0679-1328
Cecilia Pérez BrandánUnidad de Biotecnología y Protozoarios (UBIPRO), Instituto de Patología Experimental "Dr. Miguel Ángel Basombrío" (IPE), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Nacional de Salta, Salta A4400, Argentina.ORCID 0000-0002-9282-0959
Natalia S CorbalánLaboratorio de Biotecnología Microbiana, Escuela de Biología-Facultad de Ciencias Naturales, Universidad Nacional de Salta, Salta A4400, Argentina.
Leonardo AcuñaUnidad de Biotecnología y Protozoarios (UBIPRO), Instituto de Patología Experimental "Dr. Miguel Ángel Basombrío" (IPE), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Nacional de Salta, Salta A4400, Argentina.ORCID 0000-0001-5699-4583

Funding

Argentinian National Agency for Scientific and Technological Promotion PICT 2020-2519Fundacion Florencio FioriniNational University of Salta 2701/0 and 2716/0
6 · The paper itself

Abstract

American tegumentary leishmaniasis (ATL) remains a therapeutic challenge due to the toxicity and limited effectiveness of conventional agents. This study evaluated

Indexed as

amphotericin Bantileishmanial activitycell-free supernatantcutaneous infectionEnterococcus mundtiilactic acid bacterialeishmaniasisneglected tropical diseasestherapeutic alternative

Identifiers

PMID42784355
PMCPMC13611227

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.